Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience.
Disease activity
Follow-up study
Juvenile idiopathic arthritis
Multicentre study
Remission
Transition
Uveitis
Journal
Pediatric rheumatology online journal
ISSN: 1546-0096
Titre abrégé: Pediatr Rheumatol Online J
Pays: England
ID NLM: 101248897
Informations de publication
Date de publication:
01 Oct 2022
01 Oct 2022
Historique:
received:
06
05
2022
accepted:
13
09
2022
entrez:
1
10
2022
pubmed:
2
10
2022
medline:
5
10
2022
Statut:
epublish
Résumé
With juvenile idiopathic arthritis (JIA), there are several protocols and practices used worldwide for the transition from paediatric to adult care. In this study, we examined the transferral rates and disease activity after transition, as well as the disease- and health-related outcomes. We also introduce the transition practices employed in the Nordic countries. The study population comprised 408 participants with a disease onset from 1997 to 2000 who attended an 18-year follow-up visit in this population-based Nordic JIA cohort study. The patients were retrospectively divided into three subgroups: Patients transferred directly from paediatric care to adult rheumatology care, patients referred there later, and patients never transferred during the 18-year follow-up period. One hundred and sixty-three (40%) JIA patients had been directly transferred to an adult clinic. The cumulative transition rate was 52%, but there were significant differences between the participating centres. Fifty patients had later been referred to an adult clinic. Among the 195 patients who had never been transferred, 39% were found to have disease activity at the study visit. This study highlights the need to reconsider transition practices to avoid our undesirable finding of patients with disease activity in JIA, but no appropriate health care follow-up.
Sections du résumé
BACKGROUND
BACKGROUND
With juvenile idiopathic arthritis (JIA), there are several protocols and practices used worldwide for the transition from paediatric to adult care. In this study, we examined the transferral rates and disease activity after transition, as well as the disease- and health-related outcomes. We also introduce the transition practices employed in the Nordic countries.
METHODS
METHODS
The study population comprised 408 participants with a disease onset from 1997 to 2000 who attended an 18-year follow-up visit in this population-based Nordic JIA cohort study. The patients were retrospectively divided into three subgroups: Patients transferred directly from paediatric care to adult rheumatology care, patients referred there later, and patients never transferred during the 18-year follow-up period.
RESULTS
RESULTS
One hundred and sixty-three (40%) JIA patients had been directly transferred to an adult clinic. The cumulative transition rate was 52%, but there were significant differences between the participating centres. Fifty patients had later been referred to an adult clinic. Among the 195 patients who had never been transferred, 39% were found to have disease activity at the study visit.
CONCLUSION
CONCLUSIONS
This study highlights the need to reconsider transition practices to avoid our undesirable finding of patients with disease activity in JIA, but no appropriate health care follow-up.
Identifiants
pubmed: 36182898
doi: 10.1186/s12969-022-00742-2
pii: 10.1186/s12969-022-00742-2
pmc: PMC9526898
doi:
Substances chimiques
Antirheumatic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
84Informations de copyright
© 2022. The Author(s).
Références
J Rheumatol. 2004 Feb;31(2):390-2
pubmed: 14760812
J Rheumatol. 2003 Oct;30(10):2275-82
pubmed: 14528529
Int J Rheum Dis. 2017 May;20(5):567-575
pubmed: 28524619
J Rheumatol. 2004 Nov;31(11):2290-4
pubmed: 15517647
J Rheumatol. 2013 May;40(5):715-24
pubmed: 23418376
Ann Rheum Dis. 2016 Jan;75(1):190-5
pubmed: 25362042
Arthritis Res Ther. 2019 Jul 8;21(1):168
pubmed: 31287015
Ann Rheum Dis. 2016 Apr;76(4):639-646
pubmed: 27802961
J Adolesc Health. 2008 Apr;42(4):335-43
pubmed: 18346658
Scand J Rheumatol. 2022 Mar 11;:1-5
pubmed: 35272583
Arthritis Rheum. 2011 Sep;63(9):2809-18
pubmed: 21560116
Arthritis Rheum. 1995 Jan;38(1):44-8
pubmed: 7818570
Pediatr Rheumatol Online J. 2010 Jul 08;8:20
pubmed: 20615240
J Adolesc Health. 2015 Jun;56(6):612-8
pubmed: 26003575
Dev Sci. 2010 Nov;13(6):F15-24
pubmed: 20977551
Semin Arthritis Rheum. 2017 Oct;47(2):269-275
pubmed: 28583690
BMC Complement Altern Med. 2014 Apr 04;14:124
pubmed: 24708564
Arthritis Rheum. 1980 Feb;23(2):137-45
pubmed: 7362664
Pediatr Rheumatol Online J. 2018 Aug 3;16(1):50
pubmed: 30075795
Ann N Y Acad Sci. 2008 Mar;1124:111-26
pubmed: 18400927
Rheumatology (Oxford). 2021 Dec 1;60(12):5560-5566
pubmed: 33591311
Curr Rheumatol Rep. 2019 Sep 6;21(10):57
pubmed: 31492991
Rheumatology (Oxford). 2013 Nov;52(11):1999-2003
pubmed: 23893666
Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S105-10
pubmed: 17083772
Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1086-1094
pubmed: 29652654
Arthritis Care Res (Hoboken). 2020 Apr;72(4):507-516
pubmed: 30762291
Ocul Immunol Inflamm. 2013 Dec;21(6):478-85
pubmed: 23957455
Arthritis Rheum. 2005 Jul;52(7):2092-102
pubmed: 15986372
Neurosci Biobehav Rev. 2010 Apr;34(5):631-48
pubmed: 20026110